Tomas Blomquist: New CEO & President of Biotage

28-May-2019 - Sweden

Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB. Tomas Blomquist, most recently Vice President EMEA Cardimetabolic at Abbott, will start his assignment on November 6, 2019, and will then take over the responsibility for the Biotage group and its + 400 employees. Tomas Blomquist has been in the Life Sciences industry for a long time and comes with sales and management experiences from Alere, Analyticon, Johnson & Johnson and Roche.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances